Literature DB >> 10428214

Enhancement of polylysine-mediated transferrinfection by nuclear localization sequences: polylysine does not function as a nuclear localization sequence.

C K Chan1, D A Jans.   

Abstract

Polylysine (pLy) has been used successfully as a DNA carrier in receptor-mediated gene transfer, enhancement of transfection having been proposed to be in part through efficient nuclear targeting stemming from the resemblance of pLy to the nuclear localization sequence (NLS) from simian virus SV40 large tumor antigen (T-ag). In this study we test whether pLy carrying covalently attached peptides comprising the T-ag NLS (the pLyP101 derivative) can enhance transferrin-pLy-mediated transfection ("transferrinfection"). Unlike pLy itself or a pLy derivative (pLyP101T) carrying cross-linked T-ag NLS mutant peptides, pLyP101 significantly enhanced transferrinfection of a beta-galactosidase-expressing reporter plasmid. The basis of this was shown to be the ability of the pLyP101-plasmid DNA complex to be recognized with high affinity by the NLS-binding importin subunits, in contrast to pLyP101T- and pLy-plasmid complexes. Confocal laser scanning microscopy was used to determine the nuclear import kinetics of fluorescently labeled pLyP101 and pLyP101T in the presence of complexed plasmid, indicating that pLyP101 and not pLyP101T complexes accumulated rapidly in the nucleus. We conclude that pLy itself does not function as an NLS and that the addition of exogenous NLSs conferring interaction with the cellular nuclear import machinery can increase transferrinfection by enhancing the nuclear targeting of pLy-DNA complexes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10428214     DOI: 10.1089/10430349950017699

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  12 in total

Review 1.  Applying horizontal gene transfer phenomena to enhance non-viral gene therapy.

Authors:  Jacob J Elmer; Matthew D Christensen; Kaushal Rege
Journal:  J Control Release       Date:  2013-08-30       Impact factor: 9.776

Review 2.  Intracellular trafficking of nucleic acids.

Authors:  Rui Zhou; R Christopher Geiger; David A Dean
Journal:  Expert Opin Drug Deliv       Date:  2004-11       Impact factor: 6.648

Review 3.  Nuclear entry of nonviral vectors.

Authors:  D A Dean; D D Strong; W E Zimmer
Journal:  Gene Ther       Date:  2005-06       Impact factor: 5.250

Review 4.  The nuclear pore complex: the gateway to successful nonviral gene delivery.

Authors:  Marieke A E M van der Aa; Enrico Mastrobattista; Ronald S Oosting; Wim E Hennink; Gerben A Koning; Daan J A Crommelin
Journal:  Pharm Res       Date:  2006-03-15       Impact factor: 4.200

5.  Quantitative comparison between poly(L-arginine) and poly(L-lysine) at each step of polyplex-based gene transfection using a microinjection technique.

Authors:  Tomoko Hashimoto; Takeshi Kawazu; Takeshi Nagasaki; Akira Murakami; Tetsuji Yamaoka
Journal:  Sci Technol Adv Mater       Date:  2012-02-09       Impact factor: 8.090

Review 6.  Gene therapy of cystic fibrosis (CF) airways: a review emphasizing targeting with lactose.

Authors:  D T Klink; M C Glick; T F Scanlin
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

Review 7.  Controlling subcellular delivery to optimize therapeutic effect.

Authors:  Mohanad Mossalam; Andrew S Dixon; Carol S Lim
Journal:  Ther Deliv       Date:  2010-07

8.  Silica nanoparticles as a delivery system for nucleic acid-based reagents.

Authors:  Christopher Hom; Jie Lu; Fuyuhiko Tamanoi
Journal:  J Mater Chem       Date:  2009-01-01

9.  Amphiphilic block copolymers enhance cellular uptake and nuclear entry of polyplex-delivered DNA.

Authors:  Zhihui Yang; Gaurav Sahay; Srikanth Sriadibhatla; Alexander V Kabanov
Journal:  Bioconjug Chem       Date:  2008-08-27       Impact factor: 4.774

Review 10.  NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease.

Authors:  Daniel Martinez-Fong; Michael J Bannon; Louis-Eric Trudeau; Juan A Gonzalez-Barrios; Martha L Arango-Rodriguez; Nancy G Hernandez-Chan; David Reyes-Corona; Juan Armendáriz-Borunda; Ivan Navarro-Quiroga
Journal:  Nanomedicine       Date:  2012-03-07       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.